Picture of InVivo Therapeutics Holdings logo

NVIVQ — InVivo Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Deals of the day-Mergers and acquisitions

April 28 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1500 GMT on
Wednesday:

    ** 3D-printing technology provider Shapeways Inc said on
Wednesday it has agreed to go public through a merger with
blank-check acquisition firm Galileo Acquisition Corp  GLEO.N 
at a valuation of $410 million, including debt.  urn:newsml:reuters.com:*:nL8N2MK7R3
    
    ** U.S. health insurer Humana Inc  HUM.N  said on Tuesday it
will acquire the 60% stake that it did not own in home health
and hospice provider Kindred at Home from TPG Capital for $5.7
billion to expand its patient care business.  urn:newsml:reuters.com:*:nL4N2MK4JT
    
    ** Pfizer Inc  PFE.N  on Wednesday said it has acquired
privately held Amplyx Pharmaceuticals, which is developing a new
treatment for drug-resistant "superbug" fungal infections in
patients with compromised immune systems.  urn:newsml:reuters.com:*:nL1N2MJ2Y8
    
    ** Chubb Ltd's  CB.BN  chief executive officer on Wednesday
crushed the idea of buying its smaller insurance rival, the
Hartford Financial Services Group Inc  HIG.N , saying "the
chapter with the Hartford is closed."  urn:newsml:reuters.com:*:nL1N2ML1GH
    
    ** EU antitrust regulators are unlikely to demand more
concessions from insurance broker Aon  AON.N  over its $30
billion bid for Willis Towers Watson  WLTW.O  and are expected
to give conditional clearance to the deal, people familiar with
the matter said.  urn:newsml:reuters.com:*:nL8N2ML6A9
    
    ** French cooperative InVivo  NVIV.O  expects to sign an
agreement to buy rival agribusiness Soufflet in the next two
weeks, InVivo's chief executive said on Wednesday.  urn:newsml:reuters.com:*:nL1N2ML1L9



 (Compiled by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com;))

Recent news on InVivo Therapeutics Holdings

See all news